Pharmaboom Articles

Palatin Technologies,
Inc. (Amex: PTN) announced that dosing has been initiated in a Phase
2a clinical study of PL-3994, a novel, long-acting natriuretic peptide
receptor A agonist, in subjects with controlled hypertension.
The study is placebo-controlled and double-blinded, and will include up
to five cohorts receiving escalating doses. As many as 35 subjects will be
included, with six active Read the rest of this entry »

FDA on Thursday is expected to issue an advisory that urges physicians to conduct genetic testing before prescribing GlaxoSmithKline’s antiretroviral drug abacavir to reduce allergic reactions in people taking the drug, the New York Times reports. The recommendation to conduct genetic screenings will be included in a black box Read the rest of this entry »

Poor sleep quality and insomnia are significantly associated with suicidal symptoms among college undergraduates, according to a research abstract presented on Monday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
The study, authored by Rebecca A. Bernert, of Florida State University, focused on 322 college undergraduates between 19-24 years of age. The following symptom measures were administered: Pittsburgh Read the rest of this entry »

University of Florida researchers have identified a drug compound that dramatically lowers blood pressure, improves heart function and - in a remarkable finding - prevents damage to the heart and kidneys in rats with persistent hypertension.
The findings, which appear in the May 1 edition of the American Heart Association journal Hypertension, could lead to a new class of antihypertensive Read the rest of this entry »

Cook Medical , announced the launch of www.MensHealthPD.com, an informational microsite dedicated to educating physicians, men and their partners about the symptoms, treatment options and latest research on Peyronie’s disease, a common form of erectile dysfunction thought to affect more than 80, 000 men in the UK, with one study suggesting 1% of the male population may suffer. Read the rest of this entry »

At the request of the U.S. Food and Drug Administration, U.S. Marshals seized more than 14,000 dosage units of Shangai Regular, Shangai Ultra, Super Shangai, Natural?« Super Plus, and Lady Shangai. Although labeled as natural supplements, the seized products were all marketed to treat erectile dysfunction (ED), impotency, and/or to provide sexual enhancement, which Read the rest of this entry »

Results of a new analysis of the Treating to New Targets (TNT) study show that intensive low-density lipoprotein (LDL) cholesterol-lowering in patients with stable coronary heart disease (CHD) whose systolic blood pressure was less than 140 mmHg reduced the risk of major cardiovascular events, including heart attack, stroke Read the rest of this entry »

NeuroInvestment announced the release of its May issue, which reviews novel treatments being developed for depression. Even though depression can be argued to be the success story of psychopharmacology, the current array of largely similar monoamine-targeting drugs leave 30% of patients without adequate relief, and incur significantly Read the rest of this entry »

Men’s Health News
Buy generic propecia Plans are in the pipeline to raise awareness of health issues which affect men in particular.
The Federal Health Minister Nicola Roxon says the government has set in Read the rest of this entry »

In The Lancet, international health experts call for urgent action from international development banks and pharmaceutical companies to stem the epidemic of blood pressure-related diseases affecting developing countries worldwide.
New findings reveal that each year 8 million people die from heart disease and stroke, the two leading blood pressure-related diseases. The majority of these deaths occur in the developing world where victims are Read the rest of this entry »